Bevin Gangadharan

I have been working part-time in the Centre for Immuno-Oncology since September 2025, where I operate and maintain the liquid chromatography and mass spectrometry platforms used for immunopeptidomics research. Our centre is equipped with state-of-the-art instrumentation, including two Thermo Astral mass spectrometers, a Bruker timsTOF SCP, a Thermo Vanquish Neo UHPLC, two EvoSep Eno LCs and a Bruker nanoElute 2.

I completed my DPhil in Prof. Nicole Zitzmann’s lab in the Department of Biochemistry at the University of Oxford, where I specialised in proteomics, mass spectrometry and liver disease biomarker discovery. My first experience in proteomics was during industrial placements at SmithKline Beecham and GlaxoSmithKline, and I now have over two decades of experience in the field, spanning both discovery and targeted LC-MS/MS. I am also an inventor on three international patents relating to biomarkers for liver disease, including metabolic dysfunction-associated steatotic liver disease (MASLD), a condition that affects approximately one-third of the global population (over 1.3 billion people worldwide).

Alongside my role in the Centre for Immuno-Oncology, I continue to work part-time in the Department of Biochemistry, where I collaborate closely with the Medicine Quality Research Group led by Prof. Paul Newton on projects aimed at improving medicine quality and patient safety worldwide.

As part of the Vaccine Identity Evaluation (VIE) programme, I help develop novel low-cost technologies to identify falsified and substandard vaccines. I have led projects using MALDI-TOF mass spectrometry, hospital biochemical analysers, drying vaccines on black electricians’ tape, colorimetric assays and other innovative approaches to detect counterfeit and degraded vaccines.

I am also a member of the Oxford DEG/EG team, which addresses the global problem of diethylene glycol and ethylene glycol contamination in medicinal syrups. These contaminants have caused the deaths of hundreds of children worldwide. I have led the development of rapid (under two minutes) and low-cost (under £1 per test) tests for their detection.

In addition to my research, I have extensive experience mentoring undergraduate Part II, DPhil and postdoctoral researchers. I serve on the editorial board of Biomarker Research and am committed to communicating science both within academia and to the wider public. I regularly present my work at national and international conferences and participate in outreach activities that promote public engagement with science.